Elsevier

Clinical Biochemistry

Volume 37, Issue 11, November 2004, Pages 1031-1036
Clinical Biochemistry

Induced sputum in cystic fibrosis: within-week reproducibility of inflammatory markers

https://doi.org/10.1016/j.clinbiochem.2004.07.008Get rights and content

Abstract

Analysis of induced sputum has provided significant insight into the inflammatory response in chronic respiratory diseases such as asthma. The thick, tenacious nature of cystic fibrosis (CF) sputum presents certain challenges to such evaluation. We describe the development of a methodology to assess CF sputum, and the within-week reproducibility (to limit the possibility of any change in clinical status) of cellular and inflammatory markers.

Methods

Seventeen young adults [9 males, 8 females, mean age 24 (5), median (quartile range) years, percentage of predicted FEV1 = 64.0 (18.0%)] with CF underwent sputum inductions on the Monday and Thursday of the same week. Patients were pretreated with 400 μg salbutamol and subsequently inhaled 5% saline via a breath enhanced nebulizer. Every 3-min nebulization was interrupted to allow for expectoration of sputum into a polypropylene pot. Sputum samples were dispersed with a solution of dithiothreitol (DTT) and deoxyribonuclease to allow for analysis of total cell count (TCC) and percentage neutrophils (%Neut). Measurement of tumor necrosis factor-α (TNF-α), interleukin-8 (IL-8), and neutrophil elastase was performed on samples dispersed with DTT alone.

Results

There were no significant differences between the measurements taken in the same week. Values for Day 1 versus Day 2 were as follows: TCC 20.8 (6.4) vs. 17.6 (2.5) × 106 cells/ml; %Neut: 94.1 (0.0) vs. 95.4 (0.5) %; TNF-α 7.5 (26.0) vs. 21.0 (44.0) pg/ml; IL-8 610.0 (422.0) vs. 524.0 (587.0) ng/ml and neutrophil elastase 110.0 (19.75) vs. 49.75 (60.75) μM. High intraclass correlation coefficients (ICC) for TCC, %Neut, TNF-α IL-8 and neutrophil elastase were found (ICC = 0.76, 0.82, 0.93, 0.82, 0.74, respectively).

Conclusions

The method developed here for the analysis of CF sputum shows good reproducibility and can be used to evaluate therapeutic interventions in patients with cystic fibrosis.

Introduction

The measurement of cell11ular and cytokine profiles in sputum as markers of inflammation offers a noninvasive method to determine lower airway inflammation in different disease processes [1], [2], [3]. Cystic fibrosis (CF) is characterized by lung inflammation resulting from chronic infection and the subsequent neutrophilic migration to the airways mediated by cytokines. Tumor necrosis factor-α (TNF-α), a proadhesion cytokine, allows for the subsequent diapedesis and migration of neutrophils into the damaged lung areas [4]. Furthermore, interleukin-8 (IL-8) activates neutrophils and sets up a chemotactic gradient, permitting their migration [5]. This chronic neutrophilic inflammation leads to an excess of free neutrophil elastase on the epithelial surface [6], which can injure epithelial cells and contribute to the loss of host defense systems [7]. In addition, the degeneration of the polymorphonuclear neutrophils causes the release of deoxyribonuclease from their nuclei, which in turn increases the viscosity of the CF sputum [8]. Due to the thick, tenacious nature of CF sputum, it is important to first establish the reproducibility of the actual measures in sputum to assess changes in cytokine and cellular markers. This analysis of induced sputum will further our understanding of the inflammatory process in CF and may thereby permit an evaluation of the response to therapies.

There have been many studies utilizing various dispersal agents and methods for specific biochemical and cellular evaluations of sputum from different patient populations [2], [9], [10], [11], [12], [13], [14], [15]. These have examined reproducibility of sputum fluid phase and cellular indices of airway inflammation in asthmatics [16], [17], [18], [19], [20], smokers [17], patients with COPD [21], and healthy subjects [17], [20], [22]. In patients with CF, sputum reproducibility studies have been rare. Ordoñez et al. [23] reported cytokine and cellular reproducibility in induced sputum of CF patients, dispersed with dithiothreitol, done on two study visits separated by 3 weeks of placebo treatment.

Dithiothreitol (DTT) is commonly used for the dispersal of sputum samples from asthma patients and shown to give reliable measurements of cellular and fluid-phase markers [12]. Cai et al. [13] showed that DTT alone was not as effective as DTT with the triple enzyme mixture [deoxyribonuclease (DNase), hyaluronidase, and β-galactosidase] in dispersing CF sputum perhaps because of the viscosity. Total cell counts (TCCs) and neutrophil counts were higher in the samples treated with DTT and enzyme mixture, but elastase immunoreactivity was lost. We used a modification of this method to assess the reproducibility of sputum samples taken within the same week for total and differential cell counts, IL-8, TNF-α, and neutrophil elastase. Within-week reproducibility was assessed to minimize the risk of changes due to the clinical condition and allowed for the assessment of biological variability in two separate induced sputum samples.

Section snippets

Subjects

Seventeen patients with a diagnosis of cystic fibrosis underwent sputum induction twice within the same week (3 days apart) with no change in patient management. All subjects were required to have been stable (no hospitalizations or courses of oral corticosteroids) for 2 months before entrance to the study. The study was approved by the Montreal Children's Hospital's Review Board and all subjects gave informed consent.

Sputum induction and processing

Before commencement of the sputum induction procedure, subjects were

Results

Of the 17 subjects (9 males, 8 females) [24.0 (5.0) years of age, 64.0 (18.0) FEV1 %predicted, median (quartile range)], there were 2 occasions where insufficient sample was obtained to allow for both chemical and cellular analysis. All patients tolerated the induction procedure; however, lung function was not measured during the procedure. One set of samples for %Neut and TNF-α analysis was discarded due to technical error. Data analysis was subsequently performed on 15 sample sets for TCC

Discussion

Our results show good reliability in our methodology for TCC, percentage of neutrophil counts, IL-8, and neutrophil elastase. Within-week reproducibility was chosen to avoid changes in clinical status, which can occur over several weeks. Prior studies have looked at cytokine and cellular analysis. The intraclass correlation coefficients are similar to those previously published in terms of cellular markers in other patient populations [1], [17], [18], [22]. The cell counts in our patients are

References (36)

  • C.E. Brightling et al.

    Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability

    Respir. Med.

    (2001)
  • S.D. Sagel et al.

    Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis

    J. Pediatr.

    (2002)
  • V.M. Keatings et al.

    Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma

    Am. J. Respir. Crit. Care Med.

    (1996)
  • I. Pin et al.

    Use of induced sputum cell counts to investigate airway inflammation in asthma

    Thorax

    (1992)
  • M.M. Pizzichini et al.

    Spontaneous and induced sputum to measure indices of airway inflammation in asthma

    Am. J. Respir. Crit. Care Med.

    (1996)
  • R.M. Streiter et al.

    Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung

    Thorax

    (1993)
  • M. Baggiolini et al.

    Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

    J. Clin. Invest.

    (1989)
  • S. Suter et al.

    Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa

    J. Infect. Dis.

    (1986)
  • P. Birrer et al.

    Protease–antiprotease imbalance in the lungs of children with cystic fibrosis

    Am. J. Respir. Crit. Care Med.

    (1994)
  • R.L. Henry et al.

    Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis

    Pediatr. Pulmonol.

    (1998)
  • P.S. Salva et al.

    TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients

    Pediatr. Pulmonol.

    (1996)
  • T. Popov et al.

    The evaluation of a cell dispersion method of sputum examination

    Clin. Exp. Allergy

    (1994)
  • E. Pizzichini et al.

    Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination

    Eur. Respir. J.

    (1996)
  • A. Efthimiadis et al.

    Induced sputum cell and fluid phase indices of inflammation: comparison of treatment with dithiothreitol vs. phosphate-buffered saline

    Eur. Respir. J.

    (1997)
  • Y. Cai et al.

    Comparison of sputum processing techniques in cystic fibrosis

    Pediatr. Pulmonol.

    (1996)
  • K.W. Tsang et al.

    Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis

    Am. J. Respir. Crit. Care Med.

    (1998)
  • A. Bhowmik et al.

    Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

    Thorax

    (2000)
  • J.V. Fahy et al.

    Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study

    Am. J. Respir. Crit. Care Med.

    (2001)
  • Cited by (0)

    View full text